Quantit
By Lana Pine | Published on February 26, 2026 5 min read A new head-to-head clinical trial published in The Lancet suggests that an investigational once-daily pill, orforglipron, may offer stronger blood sugar and weight loss benefits than oral semaglutide for adults with Type 2 diabetes who are not adequately controlled on metformin
Divide the dose by the concentration
"Most insurance providers require a prior authorization form to cover these irrespective of a generic or brand," Broussenko said, noting for patients navigating that process, the platform provides dedicated support to help complete prior authorization paperwork, aiming to prevent gaps in treatment
Use of Products: Suppliers products are intended only for research purposes unless otherwise explicitly stated
Steiber A, Kerner J, Hoppel CL (2004)